188 related articles for article (PubMed ID: 7737912)
1. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan.
Fukuda H; Saito D; Hayashi S; Hisai H; Ono H; Yoshida S; Oguro Y; Noda T; Sato T; Katoh M
Jpn J Cancer Res; 1995 Jan; 86(1):64-71. PubMed ID: 7737912
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
4. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
6. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.
Watanabe Y; Kurata JH; Mizuno S; Mukai M; Inokuchi H; Miki K; Ozasa K; Kawai K
Dig Dis Sci; 1997 Jul; 42(7):1383-7. PubMed ID: 9246033
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
[TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
[TBL] [Abstract][Full Text] [Related]
10. Severe atrophic gastritis with Helicobacter pylori infection and gastric cancer.
Kitahara F; Shimazaki R; Sato T; Kojima Y; Morozumi A; Fujino MA
Gastric Cancer; 1998 Mar; 1(2):118-124. PubMed ID: 11957055
[TBL] [Abstract][Full Text] [Related]
11. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
[TBL] [Abstract][Full Text] [Related]
16. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea.
Kang JM; Kim N; Yoo JY; Park YS; Lee DH; Kim HY; Lee HS; Choe G; Kim JS; Jung HC; Song IS
Helicobacter; 2008 Apr; 13(2):146-56. PubMed ID: 18321304
[TBL] [Abstract][Full Text] [Related]
17. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.
Abnet CC; Zheng W; Ye W; Kamangar F; Ji BT; Persson C; Yang G; Li HL; Rothman N; Shu XO; Gao YT; Chow WH
Br J Cancer; 2011 Apr; 104(9):1511-6. PubMed ID: 21407214
[TBL] [Abstract][Full Text] [Related]
18. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
19. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.
Bodger K; Wyatt JI; Heatley RV
Helicobacter; 2001 Sep; 6(3):216-24. PubMed ID: 11683924
[TBL] [Abstract][Full Text] [Related]
20. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
